SLC5A1 and diabetes mellitus: Seidelmann et al. (32) reported that the heterozygosity of missense variants in SLC5A1, leading to reduced SGLT-1 function, was associated with a significant reduction in the risk of diabetes, HF, and cardiovascular death in patients.